These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12822385)

  • 1. [Angiotensin II antagonists in the treatment of cardiac decompensation].
    Gerc V; Buksa M
    Med Arh; 2003; 57(2):109-14. PubMed ID: 12822385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure.
    Chang PI; Pitt B
    Cardiologia; 1994 Dec; 39(12 Suppl 1):409-11. PubMed ID: 7634306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on therapy for heart failure.
    DiBianco R
    Am J Med; 2003 Oct; 115(6):480-8. PubMed ID: 14563505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure.
    Manohar P; Piña IL
    Mayo Clin Proc; 2003 Mar; 78(3):334-8. PubMed ID: 12630586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring new treatment strategies in heart failure.
    Swedberg K
    Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.
    Brunner-La Rocca HP; Vaddadi G; Esler MD
    J Am Coll Cardiol; 1999 Apr; 33(5):1163-73. PubMed ID: 10193712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
    McInnes GT
    J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
    Burnier M; Brunner HR
    Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M; Kuzuya T; Hori M
    Nihon Rinsho; 1999 May; 57(5):1148-57. PubMed ID: 10361449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure.
    Carson PE
    Am Heart J; 2000 Sep; 140(3):361-6. PubMed ID: 10966531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists in chronic heart failure: where do they fit?
    Houghton AR
    Drugs; 2002; 62(10):1433-40. PubMed ID: 12093312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.